ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

Expanded Tissue Resources, Equipment Funds Planned.

December 8, 2000

NIH Funding Opportunities Listed

March 13, 2009

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994

The Cancer Letter Marks 25th Anniversary

December 18, 1998

NCI Drops Two CCOPS, Cincinnati And West Virginia, For Lack Of Patient Entry; 60 Funded Another Year

August 24, 1984